首页 | 本学科首页   官方微博 | 高级检索  
     

重组白细胞介素-2治疗慢性肝炎22例观察
引用本文:李群,马传香,许福亮. 重组白细胞介素-2治疗慢性肝炎22例观察[J]. 潍坊医学院学报, 1995, 0(3)
作者姓名:李群  马传香  许福亮
作者单位:Department of Infectious Diseases,261042
摘    要:应用重组白细胞介素-2(rIL-2)治疗慢性活动性肝炎(CAH),对治疗前后外周血淋巴细胞亚群、乙肝病毒5项标志进行了检测,结果治疗后CD4+T细胞明显增加,CD8+T细胞明显降低(P<0.01),CD4+/CD8+倒置情况有明显改善。有2例CAH血HBeAg转阴,但未见抗-HBs阳转。本文还就rIL-2对CAH肝功能的影响进行了讨论。

关 键 词:乙型肝炎;生物治疗;白细胞介素

OBSERVATION OF EFFICACY OF rIL-2 IN 22 PATIENTS WITH CHRONIC HEPATITIS B
Li Qun, Ma Chuangxiang, Xu Fuliang. OBSERVATION OF EFFICACY OF rIL-2 IN 22 PATIENTS WITH CHRONIC HEPATITIS B[J]. Journal of Weifang Medical College, 1995, 0(3)
Authors:Li Qun   Ma Chuangxiang   Xu Fuliang
Abstract:cases with CAH had treated with rIL-2, and lymphocyte subsets, HBV marks,were observed during rIL-2 therapy. The result showed that in most case with CAH,CD4+ T-cells were increased and CD8+ T -cells were decreased after using rIL-2(P<0.01),negative conversing rate of HBeAg was 13. 3%(P> 0. 05), seroconversion of HBeAg to anti-HBs in serum. These findings suggested that rIL-2 therapy can improve immunological function in CAH, but rIL-2 therapy over shorter periods and with less doses did not resultin complete clearance of HBV.
Keywords:hepatitis B  biological therapy  rIL-2
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号